Image

Offering Cervical Cancer Screening to Older Women

Offering Cervical Cancer Screening to Older Women

Not Recruiting
65-69 years
Female
Phase N/A

Powered by AI

Overview

This study evaluates the effect and feasibility of expanding the target population in the Danish cervical cancer screening program to include women aged 65 to 69 years. The study also evaluates if HPV self-sampling constitutes an appropriate screening method among older women.

Description

The study is a nationwide population-based prospective cohort study embedded in the routine cervical cancer screening program in the Central Denmark Region. The study includes all 65 to 69 years old Danish women with no record of a cervical cytology sample or screening invitation within the last five years. Furthermore, the women are not registered as ineligible for screening, eg due hysterectomy. Eligible women residing in the Central Denmark Region are allocated to the intervention group (n=20,000), while women residing in the other four Danish regions are allocated to the control group receiving standard care (n=71,500), which for this group is low-level opportunistic screening at the general practitioner (GP). The intervention group are invited for HPV-based screening by the GP or to request a self-sampling kit.

Eligibility

Inclusion Criteria:

  • 65 to 69 years;
  • Resident in Denmark
  • No record of a cervical cytology or screening invitation in the past 5 years
  • Not registered as ineligible for screening

Exclusion Criteria:

  • Death
  • Migration to or from Denmark
  • Moving to or from the CDR
  • Residing in the CDR, but having GP in another region
  • A record of hysterectomy

Study details
    Uterine Cervical Neoplasm
    Uterine Neoplasm
    Uterine Cervical Disease
    Mass Screening

NCT04114968

University of Aarhus

30 January 2026

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.